Purple Biotech Reports Third Quarter 2023 Financial
Initial Activity in Head and Neck Cancer Demonstrated in NT219 Phase 1/2 Dose Escalation Study Patients’ Enrollment in the Phase 2 Randomized CM24...
Source: globenewswire.com
Runway Extended News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Runway Extended. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Runway Extended Today - Breaking & Trending Today
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational
Ebvallo™ EU Launch Activities Led by Pierre Fabre to Commence in Q1 2023Discussions with FDA Progressing on Potential U.S. BLA for Tab-cel®ATA188 Phase 2 EMBOLD Study Primary Data Readout On-Track for October 2023Cash Runway Extended into Q2 2024THOUSAND OAKS, Calif.--(BUSINESS WIRE)--$ATRA #CART--Atara Biotherapeut...
Source: pharmiweb.com
IRRAS AB publishes Interim Report for the period January to September 2022
/PRNewswire/ -- Financial Runway Extended during Q3 as Revenue Growth Continues "Q3 2022 represented IRRAS' 9th consecutive quarter of revenue growth, and the...
Source: prnewswire.com
DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates mVP Pivotal Protocol Complete and Ready for Submission to FDADBV Continues to Eng...
Source: teletrader.com
DBV Technologies S.A.: DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates mVP Pivotal Protocol Complete and Ready for Submission to FDADBV Continues
Source: finanznachrichten.de